IIM
TNGX icon

INTECH Investment Management’s Tango Therapeutics TNGX Stock Holding History

INTECH Investment Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$984K Sell
31,493
-6,466
-17% -$160K 0.01% 1042
2026
Q1 		$794K Sell
37,959
-982
-3% -$13.7K 0.01% 1107
2025
Q4 		$345K Buy
38,941
+10,789
+38% +$93K ﹤0.01% 1683
2025
Q3 		$236K Sell
28,152
-17,523
-38% -$119K ﹤0.01% 1966
2025
Q2 		$234K Buy
45,675
+5,518
+14% +$13.6K ﹤0.01% 2009
2025
Q1 		$55K Buy
40,157
+12,238
+44% +$30.1K ﹤0.01% 2420
2024
Q4 		$86.3K Sell
27,919
-2,991
-10% -$13.9K ﹤0.01% 2241
2024
Q3 		$238K Buy
+30,910
New +$295K ﹤0.01% 1641

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

INTECH Investment Management's TNGX Position: Q2 2026 in Review

INTECH Investment Management reduced its Tango Therapeutics (TNGX) stake by 17% in Q2 2026, selling an estimated $160K and leaving 31,493 shares worth $984K. The position accounts for 0.01% of the portfolio, ranked #1042.

INTECH Investment Management first reported a position in TNGX in Q3 2024 and has held it in 8 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • INTECH Investment Management held 31,493 shares of Tango Therapeutics worth $984K as of Q2 2026.
  • INTECH Investment Management sold 6,466 Tango Therapeutics shares in Q2 2026, an estimated $160K.
  • Tango Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1042 holding.
  • INTECH Investment Management first reported a position in Tango Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.